Filing Details
- Accession Number:
- 0000899243-23-007598
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-08 18:44:43
- Reporting Period:
- 2023-03-06
- Accepted Time:
- 2023-03-08 18:44:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1521036 | Lantheus Holdings Inc. | LNTH | In Vitro & In Vivo Diagnostic Substances (2835) | 352318913 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861113 | Daniel Niedzwiecki | C/O Lantheus Holdings, Inc. 201 Burlington Road, South Bldg Bedford MA 01730 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-06 | 9,079 | $72.56 | 75,925 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2023-03-07 | 1,055 | $72.15 | 74,870 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transactions reported in this Form 4 were effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
Billionaire Hedge Funds
